Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on the discovery, development & commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions.
Flexion is based in Burlington, Massachusetts.
View our terms of use: https://flexiontherapeutics.com/terms-of-use/